4Puzzilli F, Ruggeri A, Mastronardi L, et al. Long-term survival in cerebral glioblastoma[J]. Tumori, 1998, 84(1): 69.
5Stewart L A. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials[J]. Lancet, 2002, 359(9311): 1011.
6Mikkelsen T. Cytostatie agents in the management of malignant gliomas[J]. Cancer Control, 1998, 5: 150.
7Rutka J T, Taylor M, Mainprize T, et al. Molecular biology and neurosurgery in the third millennium[J]. Neurosurgery.2000, 46(5): 1034.
8Gutin P H, Posner J B. Neuro-oncology.: Dimaosis mad management of cerebral glioma-past, present, and future. Neurosurgery., 2000, 47(1): 1.
二级参考文献35
1Stephen B. Tatter MD, PhD.Recurrent malignant glioma in adults[J]. Current Treatment Options in Oncology . 2002 (6)
2Sackett DL,Rosenberg WM,Gray JA, et al.Evidencebased medicine: what it is and what it is not. British Medical Journal . 1996
3Evidence-based Medicine Working Group.Evidencebased Medicine: A new approach to teaching the practice of medicine-Evidence-based Medicine Working Group. The Journal of The American Medical Association . 1992
4Sobel BE,Levine MA.Medical education, evidencebased medicine, and the disqualification of physicianscientists. Experimental Biology and Medicine . 2001
5Rosenberg J,Greenberg MK.Practice parameters: strategies for survival into the nineties. Neurology . 1992
6Blomgren H.Brain tumorst. Acta Oncologica . 1996
7Huncharek M,Muscat J,Geschwind JF.Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis. Anticancer Research . 1998
8Guyotat J,Signorelli F,Frappaz D, et al.Is reoperation for recurrence of glioblastoma justified?. Oncology Reports . 2000
9Dinnes J,Cave C,Huang S, et al.The effectiveness and costeffectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review. Health Technology . 2001
10Brem H,Piantadosi S,Burger PC, et al.Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Lancet . 1995
6Yang JR, Dai R J, Yang Y, et al. Beam orientation optimization for intensity-modulated radiation therapy using mixed integer programming. Phys Med Biol,2006,51.3653-3666.
7Wang XC, Zhang XD,Dong L, et al. Development of methods for beam angle optimization for IMRT using an accelerated exhaustive search strategy. Int J Radiat Oneol Biol Phys, 2004,60: 1325- 1337.
8Rowbottom CG, Nutting CM, Webb S. Beam-orientation optimization of intensity-modulated radiotherapy : clinical application to parotid gland tumours. Radiother Oncol, 2001,59 : 169-177.
9Woudstra E, Heijmen B J, Storchi PR. Automated selection of beam orientations and segmented intensity-modulated radiotherapy (IMRT) for treatment of oesophagus tumors. Radiother Oncol, 2005,77:254-261.
10Wu Q, Mmohan R, Morris M, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head- and-neck squamous cell carcinomas I :dosimetrie results. Int J Radiat Oncol Biol Phys,2003,56:573-585.
